Developing a new platform for analyzing proteins in single cells.
Official title: SBIR PHASE II, TOPIC 420: INTEGRATED PLATFORM AND CONSUMABLES FOR ROBUST, SENSITIVE AND HIGH-THROUGHPUT SINGLE-CELL PROTEOMICS
Funded at Micromics Technologies LLC · NIH-10948319 · Data updated 2026-11-12
This study is working on a new system to make it easier for labs to study proteins in single cells, which could help improve medical research and personalized treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Micromics Technologies LLC NIH-funded |
| Lab location | 1 site (Spanish Fork, United States) |
| Project start | August 25, 2023 |
| Project end | August 24, 2025 |
| Funding year | 2023 |
| Award (this year) | $2,000,000 |
| NIH project number | 75N91023C00027-0-9999-1 |
| Project ID | NIH-10948319 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include patients with conditions that require precise biomarker identification and individualized therapy.
✕Less likely to help
Patients with conditions that do not involve protein analysis or do not require single-cell level insights may not benefit from this research.
What this research studies
This research focuses on creating an integrated platform that simplifies the process of single-cell proteomics, which is the study of proteins in individual cells. It aims to develop specialized reagents and consumables that make sample preparation easier and more accessible for laboratories. The project will also create high-performance liquid chromatography columns and a multi-column platform to enhance the speed and efficiency of protein analysis. By achieving a high throughput of analyzing 96 cells per day, this research could significantly advance the fields of biomedical research, biomarker discovery, and personalized medicine.
Why it matters
Potential benefit: If successful, this research could enable more laboratories to conduct detailed protein analyses at the single-cell level, leading to better diagnostics and personalized treatment options for patients.
How similar studies have gone: Other research has shown success in developing advanced proteomics techniques, but this specific approach to streamline single-cell analysis is relatively novel.
Where this research is happening
-
Micromics Technologies LLC
Spanish Fork, United States Active
Researchers
- Principal investigator: Kelly, Ryan — Micromics Technologies LLC
- Study coordinator: Kelly, Ryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.